BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T110000
DTEND;TZID=America/Vancouver:20211115T123000
DTSTAMP:20211108T205629Z
CREATED:20211105T180537Z
LAST-MODIFIED:20211108T205629Z
UID:19187-1636974000-1636979400@scienceinvancouver.com
SUMMARY:Hope on the Horizon for Diabetes
DESCRIPTION:Celebrating the 100th anniversary of the discovery of insulin. \nA panel of BC researchers and patients share transformative changes and treatments for diabetes. \nPresented by Institute for Healthy Living and Chronic Disease Prevention\, UBCO and BC Diabetes Research Network\, UBC \nPanel of Researchers and Patient Advocates: \n  \nNew frontiers in type 1 diabetes research and therapy: preserving and replacing insulin-producing beta cells \nDr. Bruce Verchere\, Professor Departments of Surgery and Pathology & Laboratory Medicine\, UBC Vancouver; Irving K Barber Chair in Diabetes Research \nChildhood Diabetes Labs\, BC Children’s Hospital \nDirector\, Centre for Molecular Medicine and Therapeutics \nA fundraising strategist; communications professional; sister and daughter living with type 1 diabetes \n  \nMrs. Sheila Kern – Patient Advocate and Diabetes Parent \nPrincipal Consultant at Purposefully \nformer Executive Director of Diabetes Canada BC & Yukon Chapter \nNew research showing that remission of type 2 diabetes is achievable for some people \n  \nDr. Jonathan Little\, Associate Professor \nSchool of Health and Exercise Sciences\, UBC Okanagan \nA clinical trial participant who experienced the positive impact that therapeutic nutrition can have on type 2 diabetes \n  \nMr. JJ Belanger – Patient Advocate with type 2 Diabetes \nThis event is free and open to the public.
URL:https://scienceinvancouver.com/event/hope-on-the-horizon-for-diabetes/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T110000
DTEND;TZID=America/Vancouver:20211115T123000
DTSTAMP:20211105T180537Z
CREATED:20211105T180537Z
LAST-MODIFIED:20211105T180537Z
UID:26460-1636974000-1636979400@scienceinvancouver.com
SUMMARY:Hope on the Horizon for Diabetes
DESCRIPTION:Celebrating the 100th anniversary of the discovery of insulin. \nA panel of BC researchers and patients share transformative changes and treatments for diabetes. \nPresented by Institute for Healthy Living and Chronic Disease Prevention\, UBCO and BC Diabetes Research Network\, UBC \nPanel of Researchers and Patient Advocates: \n  \nNew frontiers in type 1 diabetes research and therapy: preserving and replacing insulin-producing beta cells \nDr. Bruce Verchere\, Professor Departments of Surgery and Pathology & Laboratory Medicine\, UBC Vancouver; Irving K Barber Chair in Diabetes Research \nChildhood Diabetes Labs\, BC Children’s Hospital \nDirector\, Centre for Molecular Medicine and Therapeutics \nA fundraising strategist; communications professional; sister and daughter living with type 1 diabetes \n  \nMrs. Sheila Kern – Patient Advocate and Diabetes Parent \nPrincipal Consultant at Purposefully \nformer Executive Director of Diabetes Canada BC & Yukon Chapter \nNew research showing that remission of type 2 diabetes is achievable for some people \n  \nDr. Jonathan Little\, Associate Professor \nSchool of Health and Exercise Sciences\, UBC Okanagan \nA clinical trial participant who experienced the positive impact that therapeutic nutrition can have on type 2 diabetes \n  \nMr. JJ Belanger – Patient Advocate with type 2 Diabetes \nThis event is free and open to the public.
URL:https://scienceinvancouver.com/event/hope-on-the-horizon-for-diabetes-2/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T110000
DTEND;TZID=America/Vancouver:20211115T123000
DTSTAMP:20211105T180537Z
CREATED:20211105T180537Z
LAST-MODIFIED:20211105T180537Z
UID:28075-1636974000-1636979400@scienceinvancouver.com
SUMMARY:Hope on the Horizon for Diabetes
DESCRIPTION:Celebrating the 100th anniversary of the discovery of insulin. \nA panel of BC researchers and patients share transformative changes and treatments for diabetes. \nPresented by Institute for Healthy Living and Chronic Disease Prevention\, UBCO and BC Diabetes Research Network\, UBC \nPanel of Researchers and Patient Advocates: \n  \nNew frontiers in type 1 diabetes research and therapy: preserving and replacing insulin-producing beta cells \nDr. Bruce Verchere\, Professor Departments of Surgery and Pathology & Laboratory Medicine\, UBC Vancouver; Irving K Barber Chair in Diabetes Research \nChildhood Diabetes Labs\, BC Children’s Hospital \nDirector\, Centre for Molecular Medicine and Therapeutics \nA fundraising strategist; communications professional; sister and daughter living with type 1 diabetes \n  \nMrs. Sheila Kern – Patient Advocate and Diabetes Parent \nPrincipal Consultant at Purposefully \nformer Executive Director of Diabetes Canada BC & Yukon Chapter \nNew research showing that remission of type 2 diabetes is achievable for some people \n  \nDr. Jonathan Little\, Associate Professor \nSchool of Health and Exercise Sciences\, UBC Okanagan \nA clinical trial participant who experienced the positive impact that therapeutic nutrition can have on type 2 diabetes \n  \nMr. JJ Belanger – Patient Advocate with type 2 Diabetes \nThis event is free and open to the public.
URL:https://scienceinvancouver.com/event/hope-on-the-horizon-for-diabetes-3/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T110000
DTEND;TZID=America/Vancouver:20211115T123000
DTSTAMP:20211105T180537Z
CREATED:20211105T180537Z
LAST-MODIFIED:20211105T180537Z
UID:31158-1636974000-1636979400@scienceinvancouver.com
SUMMARY:Hope on the Horizon for Diabetes
DESCRIPTION:Celebrating the 100th anniversary of the discovery of insulin. \nA panel of BC researchers and patients share transformative changes and treatments for diabetes. \nPresented by Institute for Healthy Living and Chronic Disease Prevention\, UBCO and BC Diabetes Research Network\, UBC \nPanel of Researchers and Patient Advocates: \n  \nNew frontiers in type 1 diabetes research and therapy: preserving and replacing insulin-producing beta cells \nDr. Bruce Verchere\, Professor Departments of Surgery and Pathology & Laboratory Medicine\, UBC Vancouver; Irving K Barber Chair in Diabetes Research \nChildhood Diabetes Labs\, BC Children’s Hospital \nDirector\, Centre for Molecular Medicine and Therapeutics \nA fundraising strategist; communications professional; sister and daughter living with type 1 diabetes \n  \nMrs. Sheila Kern – Patient Advocate and Diabetes Parent \nPrincipal Consultant at Purposefully \nformer Executive Director of Diabetes Canada BC & Yukon Chapter \nNew research showing that remission of type 2 diabetes is achievable for some people \n  \nDr. Jonathan Little\, Associate Professor \nSchool of Health and Exercise Sciences\, UBC Okanagan \nA clinical trial participant who experienced the positive impact that therapeutic nutrition can have on type 2 diabetes \n  \nMr. JJ Belanger – Patient Advocate with type 2 Diabetes \nThis event is free and open to the public.
URL:https://scienceinvancouver.com/event/hope-on-the-horizon-for-diabetes-4/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T110000
DTEND;TZID=America/Vancouver:20211115T123000
DTSTAMP:20211105T180537Z
CREATED:20211105T180537Z
LAST-MODIFIED:20211105T180537Z
UID:32618-1636974000-1636979400@scienceinvancouver.com
SUMMARY:Hope on the Horizon for Diabetes
DESCRIPTION:Celebrating the 100th anniversary of the discovery of insulin. \nA panel of BC researchers and patients share transformative changes and treatments for diabetes. \nPresented by Institute for Healthy Living and Chronic Disease Prevention\, UBCO and BC Diabetes Research Network\, UBC \nPanel of Researchers and Patient Advocates: \n  \nNew frontiers in type 1 diabetes research and therapy: preserving and replacing insulin-producing beta cells \nDr. Bruce Verchere\, Professor Departments of Surgery and Pathology & Laboratory Medicine\, UBC Vancouver; Irving K Barber Chair in Diabetes Research \nChildhood Diabetes Labs\, BC Children’s Hospital \nDirector\, Centre for Molecular Medicine and Therapeutics \nA fundraising strategist; communications professional; sister and daughter living with type 1 diabetes \n  \nMrs. Sheila Kern – Patient Advocate and Diabetes Parent \nPrincipal Consultant at Purposefully \nformer Executive Director of Diabetes Canada BC & Yukon Chapter \nNew research showing that remission of type 2 diabetes is achievable for some people \n  \nDr. Jonathan Little\, Associate Professor \nSchool of Health and Exercise Sciences\, UBC Okanagan \nA clinical trial participant who experienced the positive impact that therapeutic nutrition can have on type 2 diabetes \n  \nMr. JJ Belanger – Patient Advocate with type 2 Diabetes \nThis event is free and open to the public.
URL:https://scienceinvancouver.com/event/hope-on-the-horizon-for-diabetes-5/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T120000
DTEND;TZID=America/Vancouver:20211115T130000
DTSTAMP:20211111T005717Z
CREATED:20211111T005717Z
LAST-MODIFIED:20211111T005717Z
UID:19289-1636977600-1636981200@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Job Simulation
DESCRIPTION:*Please Note* This is a two-part event series. Only register if you are able to attend both parts of the job simulation. \nEvent Summary \nHave you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? Have you heard of investment banks but unsure how they decide which project to fund? This workshop will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. \nDr. Evelyn Pau will shed light on internal processes in investment banking\, walk you through key steps in project evaluations\, and give you a taste of what you might have to do as an analyst in an investment banking industry for life sciences. Attendees will learn skills and resources to perform an opportunity assessment by conducting scientific\, medical\, and clinical due diligence\, market overview and sizing\, competitive landscape\, and other topics to better understand the business case. Attendees will conduct an assignment on Day 1 and share findings on Day 2. \nEvent Takeaways \nGain first-hand experience to conduct opportunity assessment for a new drug target\, indication\, product/technology\, or company.\nUtilize publicly available information to source data\, generate insight on value proposition\, and identify market potential and fit.\nUnderstand the role of a healthcare consultant and see examples of client projects. \n*PLEASE NOTE* This event will be held in TWO parts: \nPart 1: November 15\, 2021- 12pm-1pm PST\nPart 2: November 17\, 2021- 10am-11am PST \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nEvent Speaker \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead. \nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University. \nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-job-simulation/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/S2BN_JobSimulation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T120000
DTEND;TZID=America/Vancouver:20211115T130000
DTSTAMP:20211111T005717Z
CREATED:20211111T005717Z
LAST-MODIFIED:20211111T005717Z
UID:26465-1636977600-1636981200@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Job Simulation
DESCRIPTION:*Please Note* This is a two-part event series. Only register if you are able to attend both parts of the job simulation. \nEvent Summary \nHave you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? Have you heard of investment banks but unsure how they decide which project to fund? This workshop will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. \nDr. Evelyn Pau will shed light on internal processes in investment banking\, walk you through key steps in project evaluations\, and give you a taste of what you might have to do as an analyst in an investment banking industry for life sciences. Attendees will learn skills and resources to perform an opportunity assessment by conducting scientific\, medical\, and clinical due diligence\, market overview and sizing\, competitive landscape\, and other topics to better understand the business case. Attendees will conduct an assignment on Day 1 and share findings on Day 2. \nEvent Takeaways \nGain first-hand experience to conduct opportunity assessment for a new drug target\, indication\, product/technology\, or company.\nUtilize publicly available information to source data\, generate insight on value proposition\, and identify market potential and fit.\nUnderstand the role of a healthcare consultant and see examples of client projects. \n*PLEASE NOTE* This event will be held in TWO parts: \nPart 1: November 15\, 2021- 12pm-1pm PST\nPart 2: November 17\, 2021- 10am-11am PST \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nEvent Speaker \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead. \nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University. \nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-job-simulation-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/S2BN_JobSimulation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T120000
DTEND;TZID=America/Vancouver:20211115T130000
DTSTAMP:20211111T005717Z
CREATED:20211111T005717Z
LAST-MODIFIED:20211111T005717Z
UID:28079-1636977600-1636981200@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Job Simulation
DESCRIPTION:*Please Note* This is a two-part event series. Only register if you are able to attend both parts of the job simulation. \nEvent Summary \nHave you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? Have you heard of investment banks but unsure how they decide which project to fund? This workshop will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. \nDr. Evelyn Pau will shed light on internal processes in investment banking\, walk you through key steps in project evaluations\, and give you a taste of what you might have to do as an analyst in an investment banking industry for life sciences. Attendees will learn skills and resources to perform an opportunity assessment by conducting scientific\, medical\, and clinical due diligence\, market overview and sizing\, competitive landscape\, and other topics to better understand the business case. Attendees will conduct an assignment on Day 1 and share findings on Day 2. \nEvent Takeaways \nGain first-hand experience to conduct opportunity assessment for a new drug target\, indication\, product/technology\, or company.\nUtilize publicly available information to source data\, generate insight on value proposition\, and identify market potential and fit.\nUnderstand the role of a healthcare consultant and see examples of client projects. \n*PLEASE NOTE* This event will be held in TWO parts: \nPart 1: November 15\, 2021- 12pm-1pm PST\nPart 2: November 17\, 2021- 10am-11am PST \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nEvent Speaker \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead. \nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University. \nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-job-simulation-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/S2BN_JobSimulation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T120000
DTEND;TZID=America/Vancouver:20211115T130000
DTSTAMP:20211111T005717Z
CREATED:20211111T005717Z
LAST-MODIFIED:20211111T005717Z
UID:31162-1636977600-1636981200@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Job Simulation
DESCRIPTION:*Please Note* This is a two-part event series. Only register if you are able to attend both parts of the job simulation. \nEvent Summary \nHave you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? Have you heard of investment banks but unsure how they decide which project to fund? This workshop will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. \nDr. Evelyn Pau will shed light on internal processes in investment banking\, walk you through key steps in project evaluations\, and give you a taste of what you might have to do as an analyst in an investment banking industry for life sciences. Attendees will learn skills and resources to perform an opportunity assessment by conducting scientific\, medical\, and clinical due diligence\, market overview and sizing\, competitive landscape\, and other topics to better understand the business case. Attendees will conduct an assignment on Day 1 and share findings on Day 2. \nEvent Takeaways \nGain first-hand experience to conduct opportunity assessment for a new drug target\, indication\, product/technology\, or company.\nUtilize publicly available information to source data\, generate insight on value proposition\, and identify market potential and fit.\nUnderstand the role of a healthcare consultant and see examples of client projects. \n*PLEASE NOTE* This event will be held in TWO parts: \nPart 1: November 15\, 2021- 12pm-1pm PST\nPart 2: November 17\, 2021- 10am-11am PST \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nEvent Speaker \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead. \nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University. \nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-job-simulation-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/S2BN_JobSimulation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211115T120000
DTEND;TZID=America/Vancouver:20211115T130000
DTSTAMP:20211111T005717Z
CREATED:20211111T005717Z
LAST-MODIFIED:20211111T005717Z
UID:32622-1636977600-1636981200@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Job Simulation
DESCRIPTION:*Please Note* This is a two-part event series. Only register if you are able to attend both parts of the job simulation. \nEvent Summary \nHave you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? Have you heard of investment banks but unsure how they decide which project to fund? This workshop will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. \nDr. Evelyn Pau will shed light on internal processes in investment banking\, walk you through key steps in project evaluations\, and give you a taste of what you might have to do as an analyst in an investment banking industry for life sciences. Attendees will learn skills and resources to perform an opportunity assessment by conducting scientific\, medical\, and clinical due diligence\, market overview and sizing\, competitive landscape\, and other topics to better understand the business case. Attendees will conduct an assignment on Day 1 and share findings on Day 2. \nEvent Takeaways \nGain first-hand experience to conduct opportunity assessment for a new drug target\, indication\, product/technology\, or company.\nUtilize publicly available information to source data\, generate insight on value proposition\, and identify market potential and fit.\nUnderstand the role of a healthcare consultant and see examples of client projects. \n*PLEASE NOTE* This event will be held in TWO parts: \nPart 1: November 15\, 2021- 12pm-1pm PST\nPart 2: November 17\, 2021- 10am-11am PST \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nEvent Speaker \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead. \nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University. \nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-job-simulation-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/S2BN_JobSimulation.jpg
END:VEVENT
END:VCALENDAR